Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study-Reference-Cited by-同舟云学术

Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study

Published:2022-01 Issue:1 Volume:22 Page:e74-e79
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

LeVasseur Nathalie^ORCID,Sun Julia,Fenton David,Baxter Simon,Chan Angela,Roberts Sarah^ORCID,Feng Xiaolan^ORCID,Lohrisch Caroline^ORCID,Gelmon Karen,Shenkier Tamara,Chia Stephen K.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial;Baum;Lancet,2002

2. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6;Schmid;J Clin Oncol,2003

3. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial;Jakesz;Lancet,2005

4. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

5. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;Paik;J Clin Oncol,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays;Journal of Surgical Oncology;2024-06-24

2. Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer;Expert Review of Molecular Diagnostics;2024-01-05

3. Axillary surgery in oncologic breast surgery: a narrative review;Gland Surgery;2023-12

4. Prognostic Tests in Early-Stage Hormone Receptor–Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care;Journal of Clinical Oncology;2023-04-01

5. Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review;PLOS ONE;2023-03-10